CN Patent

CN116041336B — 一种6-氧杂螺[4,5]癸烷类化合物的新晶型、用途及其制备方法

Assigned to Chengdu Shuoder Pharmaceutical Co ltd · Expires 2024-07-09 · 2y expired

What this patent protects

本申请涉及药物晶型领域，具体涉及一种(R)‑2‑(9‑(4‑氟苯基)‑6‑氧杂螺[4,5]癸烷‑9‑基)‑N‑(2‑(吡啶‑4‑基)苄基)乙胺单盐酸盐的晶型及其制备方法。本发明所得到的式(I)化合物的晶型不易吸湿，溶解性好，具有优良的物理稳定性和化学稳定性，且其制备方法条件温和、操作简单，工艺重现性好，所得产品纯度高，使得实现工业化生产条件可控，有利于大规模产业化。

USPTO Abstract

本申请涉及药物晶型领域，具体涉及一种(R)‑2‑(9‑(4‑氟苯基)‑6‑氧杂螺[4,5]癸烷‑9‑基)‑N‑(2‑(吡啶‑4‑基)苄基)乙胺单盐酸盐的晶型及其制备方法。本发明所得到的式(I)化合物的晶型不易吸湿，溶解性好，具有优良的物理稳定性和化学稳定性，且其制备方法条件温和、操作简单，工艺重现性好，所得产品纯度高，使得实现工业化生产条件可控，有利于大规模产业化。

Drugs covered by this patent

Patent Metadata

Patent number
CN116041336B
Jurisdiction
CN
Classification
—
Expires
2024-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Shuoder Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.